Form 4: Quest Diagnostics Director Acquires Shares

Quest Diagnostics Director Wright Lassiter III acquired 1,142 shares of common stock through an award of restricted stock units.

Summary

• Wright Lassiter III, a Director at Quest Diagnostics, acquired 1,142 shares of common stock on May 20, 2026.
• The acquisition was made through an award of restricted stock units.
• Following this transaction, Lassiter III beneficially owns 10,317 shares of common stock.
• The reported shares include those acquired via dividend reinvestment under the Deferred Compensation Plan for Directors.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine share acquisition by a director, which is a standard disclosure and does not inherently indicate positive or negative performance.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition of 1,142 shares by a director indicates continued direct investment in the company.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that insider transactions, such as this share acquisition by a director, are common in the healthcare diagnostics industry and are closely watched by investors for signals of management's confidence.

Stakeholder Impact

• Shareholders: The acquisition by a director may be interpreted as a positive signal of confidence in the company's value.
• Management: Reinforces the alignment of director interests with those of shareholders.

Key Dates

Keywords

Quest Diagnostics, DGX, Form 4, Insider Trading, Director, Restricted Stock Units, Share Acquisition, Beneficial Ownership